Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Nature Immunology|May 9, 2022
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine doseYaniv Lustig, Tal Gonen, Lilac Meltzer, et al.
The Lancet. Respiratory Medicine|July 5, 2021
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workersYaniv Lustig, Einav Sapir, Gili Regev-Yochay, et al.
The New England Journal of Medicine|July 28, 2021
Covid-19 Breakthrough Infections in Vaccinated Health Care WorkersMoriah Bergwerk, Tal Gonen, Yaniv Lustig, et al.
The Lancet Regional Health. Europe|July 12, 2021
Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in IsraelGili Regev-Yochay, Sharon Amit, Moriah Bergwerk, et al.
The Journal of Infectious Diseases|December 1, 2021
Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World ExperienceMayan Gilboa, Michal Mandelboim, Victoria Indenbaum, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2017
Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysisLiat Vidal, Anat Gafter-Gvili, Gilles Salles, et al.
The Lancet. Microbe|March 24, 2023
Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort studyGili Regev-Yochay, Yaniv Lustig, Gili Joseph, et al.
Pageof 3